Pharma Journalist 7879 posts 0 comments

GSK announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or disease-related symptoms, in adult patients with intermediate or high-risk…
Read More...

Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on…
Read More...

Taking place during the 15th World ADC San Diego, the  11th World ADC Awards reunited both newcomers and leaders of the antibody-drug conjugate industry this November 6, 2024.…
Read More...

Aditum Bio and Leads Biolabs announced the formation of Oblenio Bio, which is being formed in conjunction with an exclusive option and license agreement to develop LBL-051, a…
Read More...

Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), announced that the…
Read More...

On November 1, Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-034, a humanized bispecific T-cell engaging antibody targeting both GPRC5D…
Read More...

The European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in children as young as one year of age. Specifically, the approval covers…
Read More...

Nektar Therapeutics, a global biotechnology company focused on the discovery and development of novel therapies to treat autoimmune disorders, today announced that it has entered…
Read More...

GSK’s AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada for the prevention of lower respiratory tract disease (LRTD) caused by…
Read More...

Nxera Pharma – formerly known as Sosei Group or Sosei Heptares – and Antiverse, a techbio company designing antibodies for challenging targets, have announced a multi-target partnership…
Read More...